Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Swedish Orphan Biovitrum AB (publ)
  6. News
  7. Summary
    SOBI   SE0000872095

SWEDISH ORPHAN BIOVITRUM AB (PUBL)

(SOBI)
  Report
Delayed Nasdaq Stockholm  -  11:29 2022-11-25 am EST
218.00 SEK   +0.74%
11/21Sobi - Bo Jesper Hansen proposed as new Chairman of the Board of Swedish Orphan Biovitrum AB ahead of the Annual General Meeting in 2023
AQ
11/18Vaccines and drugs in the pipeline for RSV
RE
11/18Swedish Orphan Biovitrum Proposes New Chair for May 2023 Election
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Swedish Orphan Biovitrum, ADC Therapeutics Win Recommendation For Lymphoma Medication

09/16/2022 | 07:43am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADC THERAPEUTICS SA -2.18% 3.59 Delayed Quote.-82.23%
SWEDISH ORPHAN BIOVITRUM AB (PUBL) 0.74% 218 Delayed Quote.17.77%
All news about SWEDISH ORPHAN BIOVITRUM AB (PUBL)
11/21Sobi - Bo Jesper Hansen proposed as new Chairman of the Board of Swedish Orphan Biovitr..
AQ
11/18Vaccines and drugs in the pipeline for RSV
RE
11/18Swedish Orphan Biovitrum Proposes New Chair for May 2023 Election
MT
11/18Bo Jesper Hansen proposed as new Chairman of the Board of Swedish Orphan Biovitrum AB (..
AQ
11/10Sobi Obtains US FDA Authorization for Kineret Use in Treatment of COVID-19-Related Pneu..
MT
11/10U.S. health regulator authorizes Sobi's COVID drug
RE
11/10U.S. Food and Drug Administration Issues Emergency Use Authorization for KINERET« (anak..
AQ
11/10Sobi North America, the North American Affiliate of Swedish Orphan Biovitrum AB Announc..
CI
11/04Sanofi, Astra win EU approval for prevention of infant RSV
RE
11/01Swedish Orphan Biovitrum AB Chairman of the Board Hakan Bjorklund will not be available..
AQ
More news
Financials
Sales 2022 18 213 M 1 746 M 1 746 M
Net income 2022 2 448 M 235 M 235 M
Net Debt 2022 7 062 M 677 M 677 M
P/E ratio 2022 26,5x
Yield 2022 -
Capitalization 64 526 M 6 187 M 6 187 M
EV / Sales 2022 3,93x
EV / Sales 2023 3,52x
Nbr of Employees 1 555
Free-Float 57,8%
Chart SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Duration : Period :
Swedish Orphan Biovitrum AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SWEDISH ORPHAN BIOVITRUM AB (PUBL)
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 218,00 SEK
Average target price 250,60 SEK
Spread / Average Target 15,0%
EPS Revisions
Managers and Directors
Guido Oelkers President & Chief Executive Officer
Henrik Stenqvist Chief Financial Officer
Sven Hňkan Bj÷rklund Chairman
Sven Anders Ullman Chief Medical Officer, Head-Research & Development
Christine Wesstr÷m Head-Technical Operations
Sector and Competitors